Sign In
Buy MCK
$763.91
+18.79 (+2.52%)
At Close: Jun 23, 2026
Will McKesson (MCK) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Monday, 06'th Oct 2025
McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:51am, Monday, 06'th Oct 2025
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade
06:51pm, Friday, 03'rd Oct 2025
In the closing of the recent trading day, McKesson (MCK) stood at $738.06, denoting a -2.72% move from the preceding trading day.
See How McKesson Shares Rise with Money Flows
07:28am, Wednesday, 01'st Oct 2025
McKesson Corporation (MCK) shares up 138.5% since Big Money bought big in May 2022.
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
10:50am, Friday, 26'th Sep 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
10:00am, Thursday, 25'th Sep 2025
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
McKesson Corporation (MCK) Analyst/Investor Day Transcript
04:53pm, Tuesday, 23'rd Sep 2025
McKesson Corporation (NYSE:MCK ) Analyst/Investor Day September 23, 2025 9:30 AM EDT Company Participants Brian Tyler - CEO & Director Britt Vitalone - Executive VP & CFO Kirk Kaminsky - President of
McKesson lifts annual profit forecast on plans to focus on high-margin businesses
10:05am, Tuesday, 23'rd Sep 2025
McKesson on Tuesday raised its profit forecast, as the U.S. drug distributor aims to focus on high-margin businesses such as cancer medicines to boost growth.
McKesson Corporation Highlights Strategic Growth Strategies and Unveils Updated Long-term Financial Targets at Investor Day
08:00am, Tuesday, 23'rd Sep 2025
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will host its 2025 Investor Day today, beginning at 9:30 AM ET. During the event, executive leadership will discuss the company's multi
McKesson (MCK) Rises Higher Than Market: Key Facts
06:51pm, Friday, 19'th Sep 2025
The latest trading day saw McKesson (MCK) settling at $698.31, representing a +1.19% change from its previous close.
Drug distributor McKesson to restructure segments to focus on high-margin businesses
09:10am, Thursday, 18'th Sep 2025
McKesson said on Thursday it will restructure its operations into four main segments from the current quarter as the U.S. drug distributor aims to focus on high-margin businesses such as cancer medici
McKesson Announces New Organizational Structure
08:00am, Thursday, 18'th Sep 2025
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) today announced changes to its reportable segments and organizational structure, effective in the second quarter of fiscal year 2026. T
McKesson (MCK) Outperforms Broader Market: What You Need to Know
06:51pm, Thursday, 11'th Sep 2025
The latest trading day saw McKesson (MCK) settling at $719.8, representing a +1.92% change from its previous close.
Is Trending Stock McKesson Corporation (MCK) a Buy Now?
10:01am, Thursday, 11'th Sep 2025
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
10:00am, Wednesday, 27'th Aug 2025
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
